Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Cefepime Hydrochloride And Dextrose
Generic Name
Cefepime Hydrochloride
Active Ingredient
CefepimeCategory
Other
Salt Form
Hydrochloride
Variants
2
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Cefepime Hydrochloride And Dextrose, you must consult a qualified healthcare professional.
Detailed information about Cefepime Hydrochloride And Dextrose
Cefepime is a potent fourth-generation cephalosporin antibiotic used to treat a wide range of severe bacterial infections, including pneumonia, urinary tract infections, and skin infections, by inhibiting bacterial cell wall synthesis.
The dosage of Cefepime for adults is determined by the severity of the infection, the site of the infection, and the patient's renal (kidney) function. Healthcare providers typically use the following ranges for patients with normal kidney function:
Cefepime is approved for use in pediatric patients aged 2 months to 16 years. The dosage is typically calculated based on the child's weight:
For infants under 2 months of age, safety and efficacy have not been fully established, though healthcare providers may use it in specialized neonatal intensive care settings based on clinical judgment.
Because Cefepime is primarily excreted by the kidneys, dose adjustments are mandatory for patients with impaired renal function (creatinine clearance less than 60 mL/min). Failure to adjust the dose can lead to drug accumulation and serious neurological toxicity. Healthcare providers will typically increase the dosing interval (e.g., from every 12 hours to every 24 or 48 hours) or decrease the dose amount based on the calculated GFR (Glomerular Filtration Rate).
No dosage adjustment is generally required for patients with hepatic (liver) impairment, as Cefepime is not significantly metabolized by the liver.
Geriatric patients are more likely to have decreased renal function. Therefore, healthcare providers should monitor kidney function closely and adjust the Cefepime dose accordingly to prevent toxicity.
Cefepime is administered by healthcare professionals in a clinical setting (hospital or infusion center) or through home health services.
In a hospital setting, a missed dose is unlikely as the medical staff follows a strict schedule. However, if you are receiving Cefepime at home and miss a dose, contact your healthcare provider or infusion nurse immediately for instructions. Do not double the next dose to catch up.
Symptoms of Cefepime overdose may include seizures, encephalopathy (altered mental status), and neuromuscular excitability. This is particularly common in patients with kidney disease who receive doses higher than recommended. In the event of an overdose, emergency medical treatment is required. Hemodialysis may be used to help remove the drug from the blood more quickly.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop the treatment without medical guidance, as this can lead to antibiotic resistance.
Cefepime is generally well-tolerated, but like all antibiotics, it can cause side effects. The most frequently reported adverse reactions include:
Cefepime is a potent medication that must be used with caution. The most critical safety consideration is the patient's renal function. Because the drug is cleared by the kidneys, any decrease in kidney efficiency can lead to toxic levels of the drug in the brain. Patients must also be screened for previous allergies to other antibiotics, particularly penicillins, before starting treatment.
No FDA black box warnings for Cefepime. However, there are significant warnings regarding neurotoxicity in the general labeling that carry similar clinical weight.
Before Cefepime therapy is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cefepime, cephalosporins, penicillins, or other beta-lactams. There is a risk of cross-sensitivity (about 10%) between penicillins and cephalosporins. If an allergic reaction occurs, the drug must be discontinued immediately.
There are no drugs that are strictly contraindicated for co-administration with Cefepime based on chemical incompatibility in the body; however, Live Typhoid Vaccine and Live BCG Vaccine should not be administered during Cefepime therapy. The antibiotic will kill the live bacteria in the vaccine, rendering the immunization ineffective. It is generally recommended to wait at least 48 to 72 hours after the last dose of Cefepime before receiving a live bacterial vaccine.
Cefepime must NEVER be used in the following circumstances:
Healthcare providers will perform a careful risk-benefit analysis in the following situations:
Cefepime is classified as Pregnancy Category B (under the older FDA system). This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
Cefepime is excreted in human breast milk in very low concentrations. While it is generally considered compatible with breastfeeding by the American Academy of Pediatrics, there are three potential concerns for the nursing infant:
Cefepime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. It has a high affinity for Penicillin-Binding Proteins (PBPs), specifically PBP 3 (which is essential for cell division) and PBP 2 and 1B. Cefepime is a 'zwitterion,' meaning it possesses both a positive charge (on the quaternary ammonium group at the 3rd position of the cephem nucleus) and a negative charge. This unique electrical neutrality allows it to penetrate the porin channels in the outer membrane of Gram-negative bacteria (like E. coli and Pseudomonas) much faster than third-generation cephalosporins like Ceftriaxone. Furthermore, Cefepime has low affinity for many chromosomal and plasmid-mediated beta-lactamases, making it effective against bacteria that have developed resistance to other antibiotics.
The efficacy of Cefepime is 'time-dependent.' This means that the most important factor for killing bacteria is the amount of time that the concentration of the drug in the blood remains above the Minimum Inhibitory Concentration (MIC) of the target pathogen. This is why Cefepime is often dosed multiple times a day (every 8 to 12 hours) or sometimes given as a continuous infusion in critical care settings to maintain steady levels.
Common questions about Cefepime Hydrochloride And Dextrose
Cefepime is a powerful antibiotic used to treat a variety of serious bacterial infections. Healthcare providers typically prescribe it for pneumonia, complicated urinary tract infections, and skin infections. It is also a primary treatment for febrile neutropenia, which is a fever in patients with very low white blood cell counts, often following chemotherapy. Because it is a broad-spectrum antibiotic, it can kill many different types of bacteria simultaneously. It is only used for bacterial infections and will not work for viral infections like the common cold or flu.
The most common side effects of Cefepime are generally mild and occur at the site of administration. Many patients report pain, swelling, or redness where the IV or IM injection was given. Other frequent side effects include mild diarrhea, nausea, and a skin rash. Some patients may also develop oral thrush or a vaginal yeast infection due to changes in the body's natural bacterial balance. While these are common, any side effect should be reported to a nurse or doctor to ensure it does not become more serious.
It is generally advised to avoid alcohol while being treated with Cefepime. Although Cefepime does not cause a severe chemical reaction with alcohol like some other antibiotics, alcohol can interfere with your body's ability to fight the infection. Alcohol can also lead to dehydration and may worsen side effects like dizziness or nausea. Since Cefepime is used for serious infections, your body needs all its resources to recover. Always consult your healthcare provider about your specific situation regarding alcohol consumption.
Cefepime is classified as Pregnancy Category B, meaning it is generally considered safe but should only be used if clearly necessary. Animal studies have not shown harm to the fetus, but there is limited data from high-quality studies in pregnant humans. Your doctor will weigh the severity of your infection against the potential risks to the baby. If you are pregnant or planning to become pregnant, it is vital to inform your healthcare provider before starting treatment. Most doctors prefer Cefepime over other drugs if the infection is life-threatening.
Cefepime begins working against bacteria almost immediately after it enters the bloodstream. However, you may not feel a significant improvement in your symptoms for 24 to 48 hours. The time it takes to feel better depends on the severity and location of the infection. For example, a fever might start to go down within a day, but lung symptoms from pneumonia may take longer to resolve. It is essential to complete the entire course of treatment even if you start feeling better within the first few days.
You should never stop taking Cefepime or any antibiotic suddenly without your doctor's approval. Even if your symptoms have disappeared, some bacteria may still be alive in your body. Stopping the medication early allows these remaining bacteria to multiply, which can lead to a relapse of the infection. Furthermore, survivors of an incomplete antibiotic course are more likely to develop resistance, making the drug less effective in the future. Always follow the full schedule prescribed by your healthcare team to ensure the infection is completely eradicated.
If you are receiving Cefepime in a hospital, your medical team will manage the schedule for you. If you are using it at home and miss a dose, you should contact your doctor or infusion nurse immediately for guidance. Generally, you should take the missed dose as soon as you remember, unless it is almost time for the next one. Do not double the dose to make up for a missed one, as this can increase the risk of side effects like neurotoxicity. Keeping a consistent level of the drug in your blood is key to its success.
Weight gain is not a known or typical side effect of Cefepime. Most patients taking this medication are dealing with acute, serious infections that may actually cause temporary weight loss due to decreased appetite or the body's high metabolic demand during illness. If you notice sudden swelling or rapid weight gain while taking Cefepime, it could be a sign of fluid retention or kidney issues rather than fat gain. You should report any sudden changes in weight or significant swelling in your legs or face to your healthcare provider immediately.
Cefepime can interact with several other medications, so your doctor must know your full medication list. It is often used with other antibiotics, but it should not be mixed in the same IV bag with drugs like vancomycin or aminoglycosides. It may also interact with blood thinners like Warfarin, potentially increasing the risk of bleeding. Certain diuretics (water pills) can increase the risk of kidney damage when taken with Cefepime. Always provide your healthcare provider with a list of all prescriptions, over-the-counter drugs, and supplements you are taking.
Yes, Cefepime is available as a generic medication. The brand name version, Maxipime, is no longer the only option, and several manufacturers produce generic Cefepime hydrochloride. Generic versions are required by the FDA to have the same quality, strength, and purity as the brand-name drug. Using the generic version can significantly reduce the cost of treatment for patients and hospitals. Whether you receive the brand or the generic, the clinical effect and the risks associated with the medication remain the same.
Other drugs with the same active ingredient (Cefepime)
> Warning: Stop taking Cefepime and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Cefepime, as with any broad-spectrum antibiotic, can result in the overgrowth of non-susceptible organisms (superinfection). This includes fungal infections or resistant bacterial strains like Enterococcus. Additionally, long-term or repeated use may increase the risk of developing antibiotic resistance, making future infections harder to treat.
Cefepime does not currently carry an FDA Black Box Warning. However, the FDA has issued several safety communications regarding the risk of seizures and fatal encephalopathy in patients with renal impairment who were not given appropriately reduced doses. This warning is prominently featured in the 'Warnings and Precautions' section of the official prescribing information.
Report any unusual symptoms to your healthcare provider. Monitoring for neurological changes is essential, especially in elderly patients or those with known kidney disease.
Serious adverse events, including encephalopathy, aphasia (difficulty speaking), myoclonus, seizures, and nonconvulsive status epilepticus, have been reported. Most cases occurred in patients with renal impairment who did not receive appropriate dose adjustments. Healthcare providers must monitor for signs of confusion or altered mental status.
Treatment with Cefepime alters the normal flora of the colon and may permit overgrowth of C. difficile. This can lead to severe inflammation of the colon. CDAD must be considered in all patients who present with diarrhea following antibiotic use, even months after the treatment has ended.
Prescribing Cefepime in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
Patients receiving Cefepime, especially for prolonged periods or those with underlying health issues, require regular monitoring:
Cefepime can cause side effects such as dizziness, confusion, and hallucinations. Patients should not drive or operate heavy machinery until they know how Cefepime affects them. If neurological symptoms like confusion occur, these activities must be avoided entirely.
While Cefepime does not have a direct 'disulfiram-like' reaction with alcohol (unlike some other cephalosporins), alcohol should be avoided during any severe infection. Alcohol can dehydrate the body, strain the liver, and interfere with the body's natural immune response to the infection being treated.
Cefepime should always be taken for the full duration prescribed by the healthcare provider, even if symptoms improve quickly. Stopping the drug early can allow the remaining bacteria to multiply and develop resistance. There is no 'withdrawal syndrome' associated with Cefepime, but the risk of infection relapse is high if the course is incomplete.
> Important: Discuss all your medical conditions, especially kidney disease and history of seizures, with your healthcare provider before starting Cefepime.
Since Cefepime is administered via injection, food does not affect its absorption. There are no specific restrictions regarding dairy, grapefruit, or high-fat meals. However, maintaining adequate hydration is important to help the kidneys clear the medication efficiently.
There are few documented interactions between Cefepime and herbal supplements. However, patients should be cautious with:
Cefepime can interfere with several laboratory tests, leading to false results:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as they can affect how Cefepime works or increase your risk of side effects.
Cross-sensitivity is a phenomenon where an allergy to one substance leads to an allergy to a related substance. For Cefepime, this includes:
> Important: Your healthcare provider will evaluate your complete medical history, including all past allergic reactions, before prescribing Cefepime to ensure your safety.
Healthcare providers usually recommend monitoring the infant for these symptoms or temporarily pumping and discarding milk if the mother is on a high-dose course.
Cefepime is FDA-approved for pediatric patients as young as 2 months. It is frequently used in children for the treatment of pneumonia, UTIs, and skin infections.
Patients over the age of 65 are at a significantly higher risk for adverse reactions to Cefepime.
This is the most critical special population for Cefepime. Dosage must be adjusted based on the calculated Creatinine Clearance (CrCl):
No specific adjustments are required for patients with liver disease, as the liver plays a minor role in the drug's clearance. However, these patients should still be monitored for overall clinical stability.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure the safe use of Cefepime.
| Parameter | Value |
|---|---|
| Bioavailability | 100% (IV), ~100% (IM) |
| Protein Binding | ~20% |
| Half-life | 2.0 hours (Normal renal function) |
| Tmax (IM) | 1.0 - 2.0 hours |
| Metabolism | Minimal (<15% to N-methylpyrrolidine) |
| Excretion | Renal (85% unchanged) |
Cefepime is classified as a Fourth-Generation Cephalosporin. It is related to other beta-lactam antibiotics like penicillins and carbapenems. It provides a broader spectrum of activity than third-generation drugs (like Cefotaxime) by adding better coverage against Gram-positive cocci (like Staph) and specific Gram-negative rods (like Pseudomonas).